Company Filing History:
4 out of 917 
1 out of 12 
1 out of 15,484 
Years Active: 2005-2012
Title: Walter Kisiel: Innovator in Membrane Transduction Peptides
Introduction
Walter Kisiel is a notable inventor based in Albuquerque, NM (US), recognized for his contributions to the field of biochemistry and molecular biology. He holds a total of six patents, showcasing his innovative approach to developing new methods and materials for cellular internalization.
Latest Patents
Kisiel's latest patents include groundbreaking work on membrane transduction peptides and methods for delivering materials to target cells. One of his significant inventions involves isolated polypeptides that include a membrane transduction domain of human tissue factor pathway inhibitor-2 (TFPI-2). This invention describes methods for providing a composition that allows cells to internalize materials effectively. Another notable patent focuses on a human Kunitz-type inhibitor polypeptide with enhanced antifibrinolytic activity. This polypeptide is structurally similar to the KD1 domain of human TFPI-2 and includes methods for treating subjects afflicted with cancer or precancerous conditions.
Career Highlights
Throughout his career, Walter Kisiel has worked with various organizations, including the Science and Technology Corporation. His work has significantly impacted the field of medical research, particularly in developing therapeutic strategies for cancer treatment.
Collaborations
Kisiel has collaborated with esteemed colleagues such as Hitendra S Chand and Gowthami M Arepally, contributing to the advancement of research in his field.
Conclusion
Walter Kisiel's innovative work in membrane transduction peptides and related methods highlights his significant contributions to science and medicine. His patents reflect a commitment to advancing therapeutic techniques that can improve patient outcomes.